Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography

Neuroradiology

Volumn 55, Issue 4, 2013, Pages 483-492

  Tripathi, Madhavi ^a   Dhawan, Vijay ^b   Peng, Shichun ^b   Kushwaha, Suman ^c   Batla, Amit ^d   Jaimini, Abhinav ^e   D'Souza, Maria M ^e   Sharma, Rajnish ^e   Saw, Sanjiv ^e   Mondal, Anupam ^e  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

FDG PET; IPD; MSA; PSP; SPM

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CORTICOBASAL SYNDROME; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC PARKINSON DISEASE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PARAMETRIC TEST; PARKINSON DISEASE; PARKINSONISM; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME;

DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INDIA; MALE; MIDDLE AGED; OBSERVER VARIATION; PARKINSONIAN DISORDERS; POSITRON-EMISSION TOMOGRAPHY; PREVALENCE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84879694641     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-012-1132-7     Document Type: Article

References (28)

1. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatr 55:181-184
2. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ (2002) The accuracy of diagnosis of Parkinsonian syndromes in a specialist movement disorder service. Brain 125:861-870
3. Osaki Y, Wenning GK, Daniel SE, Hughes A, Lees AJ, Mathias CJ et al (2002) Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology 59:1486-1491
4. Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T et al (1994) The metabolic topography of Parkinsonism. J Cereb Blood Flow Metab 14(5):783-801
5. Moeller JR, Nakamura T, Mentis MJ, Dhawan V, Spetsieris P, Antonini A et al (1999) Reproducibility of regional metabolic covariance patterns: comparison of four populations. J Nucl Med 40:1264-1269
6. Blin J, Baron JC, Dubois B, Pillon B, Cambon H, Cambiar J et al (1990) Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicopathological correlations. Arch Neurol 47:747-752
7. Karbe H, Grond M, Huber M, Herholz K, Kessler J, Heiss WD (1992) Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography. J Neurol 239:98-102
8. Eidelberg D, Takikawa S, Moeller JR, Dhawan V, Redington K, Chaly T et al (1993) Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease. Ann Neurol 33:518-527
9. Antonini A, Kazumata K, Feigin A, Mandel F, Dhawan V, Margouleff C et al (1998) Differential diagnosis of Parkinsonism with F-18 fluorodeoxyglucose and PET. Mov Disord 13:268-274
10. Taniwaki T, Nakagawa M, Yamada T, Yoshida T, Ohyagi Y, Sasaki M et al (2002) Cerebral metabolic changes in early multiple system atrophy: a PET study. J Neurol Sci 200:79-84
11. Eidelberg D, Dhawan V, Moeller JR, Sidtis JJ, Ginos JZ, Strother SC et al (1991) The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography. J Neurol Neurosurg Psychiatry 54:856-862
12. Laureys S, Salmon E, Garraux G, Peigneux P, Lemaire C, Degueldre C et al (1999) Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration 246: 1151-1158
13. Dhawan V, Eidelberg D (2003) PET imaging in Parkinson's disease. In: Sinha KK, Chandra P, Jha DK (eds) Advances in clinical neurosciences. The Catholic Press, Jharkand, pp 251-276
14. Eckert T, Barnes A, Dhawan V, Frucht S, Gordon MF, Feigin AS et al (2005) FDG PET in the differential diagnosis of Pakinsonian disorders. NeuroImage 26:912-921
15. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study? Neurology 42:1142-1146
16. Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL et al (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson- Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015-2018
17. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670-676
18. O'Sullivan SS, Massey LA, Williams DR, Silveria-Moriyama L, Kempster PA, Holton JL et al (2008) Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 131:1362-1372
19. Shih LC, Tarsy D (2007) Deep brain stimulation for the treatment of atypical Parkinsonism. Mov Disord 22:2149-2155
20. Zhao P, Zhang B, Gao S (2012) F-18 FDG PET study on idiopathic Parkinson's disease from several parkinsonian plus syndromes. Parkinsonism Relat Disord 12:S60-S62
21. Burn DJ, Sawle GV, Brooks DJ (1994) Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal F-18 FDOPA PET data. J Neurol Neurosurg Psychiatry 57:278-284
22. Eidelberg D, Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Chaly T et al (1995) Early differential diagnosis of Parkinson's disease with F-18 fluorodeoxyglucose and positron emission tomography. Neurology 45:1995-2004
23. Parent A, Hazrat LN (1995) Functional anatomy of the basal ganglia. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Rev 20:91-127
24. Alexander GE, Crutcher MD, DeLong MR (1990) Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. Progr Brain Res 85:119-146
25. Jellinger KA (1991) Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 14:153-197
26. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN et al (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol aging 24:197-211
27. Gai WP, Halliday GM, Blumberg PC, Geffen LB, Blessing WW (1991) Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson's disease. Brain 114:2253-2267
28. Chinaglia G, Landwehrmeyer B, Probst A, Palacios JM (1993) Serotoninergic terminal transporters are differently affected in Parkinson's disease and progressive supranuclear palsy: an autographic study with [H-3] citalopram. Neuroscience 54(3):691-699